[Retracted] Improved Cardiac Function and Attenuated Inflammatory Response by Additional Administration of Tirofiban during PCI for ST-Segment Elevation Myocardial Infarction Patients

Table 3

The levels of BNP, cTnI, and CK-MB in STEMI patients in the PCI + tirofiban and PCI groups at day 7 and 30 following PCI.

Group	BNP (ng/mL)		cTnI (ng/mL)		CK-MB (IU/L)
	Day 7 after PCI	Day 30 after PCI	Day 7 after PCI	Day 30 after PCI	Day 7 after PCI	Day 30 after PCI
PCI + tirofiban group	100.36 ± 10.32	80.21 ± 8.65^#	1.05 ± 0.09	0.66 ± 0.05^#	29.88 ± 4.89	18.22 ± 1.28^#
PCI group	114.12 ± 12.12	92.24 ± 12.35^#	1.87 ± 0.17	1.12 ± 0.12^#	35.73 ± 5.04	27.39 ± 4.11^#
	<0.001	<0.001	<0.001	<0.001	<0.001	<0.001

A total of 124 patients with STEMI were randomly assigned to PCI + tirofiban and PCI groups, 62 cases per groups. , ^# compared with before PCI and day 7 after PCI. BNP, brain natriuretic peptide; cTnI, cardiac troponin I; CK-MB, creatine kinase isoenzyme.